About
Sopris Capital is a multi-strategy investment firm founded in 2002, with a focus on long-term, patient capital. The firm invests in technology-enabled business services, healthcare IT, and healthcare services sectors, typically in Series A rounds with investments ranging from $1 million to $10 million. Sopris Capital aims to be a value-added partner, offering strategic guidance and leveraging its networks to help portfolio companies achieve their growth objectives. The firm operates with an evergreen capital base, allowing for flexibility in investment horizons. Its investment strategy emphasizes a data-driven approach and an operator-first style, fostering strong partnerships with portfolio companies. Sopris Capital also has divisions for private equity and real estate investments.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Sopris Capital's most recent investment?
- Sopris Capital participated in a Seed round for medcase in July 2021, which raised $4.1M.
- Which sectors does Sopris Capital primarily invest in?
- Sopris Capital has invested in the Health Tech & Life Sciences sector, with one portfolio company in this area.
- Can you name a notable company in Sopris Capital's portfolio?
- medcase, a B2B company founded in 2017, is a notable company in Sopris Capital's portfolio. It operates as a global network for on-demand access to medical expertise.
- What is the typical investment stage for Sopris Capital?
- Sopris Capital has participated in Seed stage investments, as seen with their investment in medcase.
- What was the investment amount for Sopris Capital's participation in medcase's Seed round?
- Sopris Capital participated in medcase's Seed round, which raised $4.1M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2002 |
|---|